Public health and IP in India: Novartis loses Gleevec patent appeal at the Supreme Court
On Monday, the Supreme Court of India dismissed the appeal brought by Novartis against the Intellectual Property Appellate Board's ...
Stefano Barazza -
Wednesday, April 03, 2013
Public health and IP in India: Novartis loses Gleevec patent appeal at the Supreme Court
Reviewed by Stefano Barazza
on
Wednesday, April 03, 2013
Rating:
Reviewed by Stefano Barazza
on
Wednesday, April 03, 2013
Rating: